- Home
- Companies
- kazakhstan
- in vitro study
Refine by
In Vitro Study Suppliers Serving Kazakhstan
45 companies found
based inDiepenbeek, BELGIUM
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...
We have specialized facilities for in vitro and in vivo offerings. Our established scientific experience and customized, collaborative approach make InnoSer the ideal ally for your company to achieve meaningful, high-quality and fast results. ...
based inNess Ziona, ISRAEL
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic ...
We are developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa (P. aeruginosa) respiratory infections, a main contributor to morbidity and mortality in this disease. Phase 1b/2a clinical study in CF patients is composed ...
based inPhiladelphia, PENNSYLVANIA (USA)
Allevi creates tools and solutions to design, engineer and build with life. Our 3D bioprinters and bioinks are used around the world to find solutions to humanity’s most difficult problems – to cure disease, to test novel drugs, and to eliminate the ...
based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
We are developing CYNK-101 as a combination treatment for multiple cancer indications. CYNK-101 is manufactured from a specific type of immune cell, NK cells, that we extract from postpartum placentas and then genetically engineer to increase cell ...
based inBrea, CALIFORNIA (USA)
NuLiv Science is a growing team of scientists, innovators, and creatives focused on developing and communicating the power of our patented ingredients. From humble beginnings starting in 1997, NuLiv Science has grown into a full range ingredient ...
InnoSlim® is a pharmaceutical-grade glucose and lipid metabolic regulator through activation of the adiponectin and AMPK signaling ...
based inHanden, SWEDEN
BioThema developes, produces and sells reagents and kits for measuring ATP by the firefly luciferase reaction. Applications include rapid cell counting, cell proliferation and cytotoxicity, immunoassays, monitoring enzymes and metabolites, reporter ...
based inCopenhagen, DENMARK
Cmbio specializes in advancements in microbiome science and multi-omics research, primarily focused on human, animal, and planetary health. With a team of over 100 experts in microbiology, bioinformatics, metabolomics, molecular biology, and data ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action. Destiny Pharma’s XF platform has advantages over traditional antibiotics. ...
based inLodi, WISCONSIN (USA)
Attwill develops and manufactures pharmaceuticals, medical devices, and biologics in the heart of Wisconsin. Attwill’s scalable production and funding solutions are well equipped to take new ideas from startup to scale. With lyophilization at ...
FILTERGuard™ is a disposable IV filter with CHG. The sterile, single-use disposable IV filter is infused with chlorhexidine gluconate (CHG) to help reduce the incidence of bloodstream infections, local infections and skin colonization in ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Scientific advisory meeting held with MHRA confirming the need of a Phase 3 study to support the improved skin permeation including potential superior efficacy claims. Exploring the feasibility of a clinical study to satisfy the Phase 3 requirements ...
based inLa Rochelle, FRANCE
We believe that innovation is the key to success in Medical Device Market. Innovation, creation & patient well-being are in our DNA, we dare to go further, whether single-handedly or in partnership with our customers, while thinking outside the box ...
StarSurf® is a surface treatment process enabling to create a rough structure on the surface of implants made of titanium and titanium alloys thus improving their biological performance of osseointegration. Implants surface finishing plays a ...
based inRio Grande, NEW JERSEY (USA)
We deliver wound therapies for superior outcomes. AediCell provides safe, effective, and easy to use products at a lower overall cost. Aedicell® is a regenerative medicine company that has developed a unique proprietary process to transform human ...
The only product on the market that combines human tissue sourced from the amniotic/chorionic membrane, umbilical cord AND placental disc —Dermavest®. This combination delivers a myriad of cell attachment proteins (CAP) including collagen, ...
based inTrabzon, TURKEY
Dogsan, the first suture manufacturer of Turkey, Middle East and Balkan states, is founded in 1970 and have a long history in suture manufacturing. Competing with the global brands, Dogsan have gained its power from 45 year of expertise, almost 50 ...
PEGELAK sutures are synthetic absorbable sterile surgical sutures which are flexible strands composed of a copolymer prepared and synthesized from 90 percent glycolide and 10 percent L-lactide (derived from glycolic and lactic acids) and are ...
based inLeipzig, GERMANY
Gamma-Service Medical GmbH is a global medical technology company in the field of isotope technology. The focus of its business activities is the development, production and sale of gamma irradiation systems for the irradiation of blood components ...
GSR C1 - Gamma irradiation of blood and blood derivatives, cell cultures, transplants for comfortable, effective and precise irradiation in transfusion medicine and research (3.8 liter irradiation ...
based inMilpitas, CALIFORNIA (USA)
BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area. BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other ...
based inShanghai, CHINA
Bioventus LLC is a medical technology company that specializes in the development and distribution of orthobiologic solutions designed to support bone healing and regeneration. The company is known for its registered trademarks such as OSTEOAMP, ...
OSTEOAMP is backed by science to meet the surgeon's need for a proven allograft that can achieve solid fusion ...
based inHillsborough, NEW JERSEY (USA)
LifeTein, located in Somerset, New Jersey, was founded in 2008 with a simple vision: understanding life sciences one protein at a time. This philosophy has formed the foundation of every peptide, protein, antibody, gene, and chemical project that we ...
based inCorona, CALIFORNIA (USA)
For over 20 years, United Endoscopy has been a leader in providing state-of-the-art refurbished medical equipment and advanced equipment repair to its customers worldwide. Since its founding in 1996 by Jeremy Cooper, United Endoscopy has ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. Headquartered in Vancouver, Canada, the company started manufacturing analytical instrumentation based on a ...
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...